Target intelligence / Profile preview

Glucosaminyl (N-acetyl) transferase 1, core 2 pseudogene 3 (GCNT1P3)

Target
GCNT1P3
Molecular classification
Pseudogene, Other (non-coding DNA segment), Not an enzyme/receptor/transporter
01

Overview

Glucosaminyl (N-acetyl) transferase 1, core 2 pseudogene 3 (GCNT1P3) is a human pseudogene annotated as related to the GCNT1 family of glycosyltransferases, but it does not encode a functional protein. Pseudogenes are generally noncoding DNA segments, sometimes transcribed but not translated, and lack established biological function or therapeutic relevance. There is no evidence for GCNT1P3 playing a role in normal physiology or disease, nor are there drugs, biomarkers, or safety concerns associated with this locus. For biomedical targeting, GCNT1 (the protein-coding gene) is the relevant entity, not GCNT1P3[4]. In summary, GCNT1P3 is not a valid therapeutic target but is instead a noncoding pseudogene. If structured biomedical data are required, questions should be refocused on GCNT1 (the enzyme), which has established biological roles.

Other names
GCNT1P3Glucosaminyl transferase 1 pseudogene 3Glucosaminyl (N-acetyl) transferase 1, core 2 pseudogene 3GCNT1 pseudogene 3
02

Mechanism of action

Not applicable

03

Biological functions

None established, as it does not encode a functional protein or known regulatory RNA[4].
04

Disease associations

None knownNo documented association with disease pathogenesis; if regulatory roles exist, they are unknown[4].

Beyond the preview

Go deeper on Glucosaminyl (N-acetyl) transferase 1, core 2 pseudogene 3 (GCNT1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosaminyl (N-acetyl) transferase 1, core 2 pseudogene 3 (GCNT1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call